SeaStar Medical Holding Corp
NASDAQ:ICU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SeaStar Medical Holding Corp
Cash from Operating Activities
SeaStar Medical Holding Corp
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SeaStar Medical Holding Corp
NASDAQ:ICU
|
Cash from Operating Activities
-$13.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$4.5B
|
CAGR 3-Years
44%
|
CAGR 5-Years
25%
|
CAGR 10-Years
21%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Operating Activities
$1.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$9.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$3B
|
CAGR 3-Years
27%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
SeaStar Medical Holding Corp
Glance View
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Tampa, Florida. The company went IPO on 2021-01-26. The firm is focused on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm is engaged in developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
See Also
What is SeaStar Medical Holding Corp's Cash from Operating Activities?
Cash from Operating Activities
-13.6m
USD
Based on the financial report for Dec 31, 2025, SeaStar Medical Holding Corp's Cash from Operating Activities amounts to -13.6m USD.
What is SeaStar Medical Holding Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-20%
Over the last year, the Cash from Operating Activities growth was 15%. The average annual Cash from Operating Activities growth rates for SeaStar Medical Holding Corp have been -20% over the past three years , -20% over the past five years .
